abstract |
A premix membrane emulsification based process is disclosed, which use polyvinylpyrrolidone as a porogenic agent for the preparation of porous microparticles for inhalation formulations in pulmonary drug delivery, as well as the microparticles and the pharmaceutical compositions produced hereof. |